{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T17:41:10Z","timestamp":1793814070927,"version":"4.6.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"NIH","award":["R24AG073137"],"award-info":[{"award-number":["R24AG073137"]}]},{"name":"NIH","award":["R24AG073137"],"award-info":[{"award-number":["R24AG073137"]}]},{"name":"NIH","award":["R24AG073137"],"award-info":[{"award-number":["R24AG073137"]}]},{"name":"NIH","award":["R24AG073137"],"award-info":[{"award-number":["R24AG073137"]}]},{"name":"NIH","award":["R24AG073137"],"award-info":[{"award-number":["R24AG073137"]}]},{"name":"NIH","award":["R24AG073137"],"award-info":[{"award-number":["R24AG073137"]}]},{"name":"NIH","award":["R24AG073137"],"award-info":[{"award-number":["R24AG073137"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Vet Res"],"DOI":"10.1186\/s12917-025-05027-w","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T13:58:41Z","timestamp":1760709521000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Plasma and cerebrospinal fluid biomarkers in aged dogs with cognitive decline"],"prefix":"10.1186","volume":"21","author":[{"given":"Abdullatif","family":"Alsulami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean W.","family":"Boland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"McGrath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan L.","family":"MacLean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin S.","family":"Latimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Darvas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A.","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,17]]},"reference":[{"key":"5027_CR1","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.tvjl.2010.05.014","volume":"188","author":"HE Salvin","year":"2011","unstructured":"Salvin HE, McGreevy PD, Sachdev PS, Valenzuela MJ. The canine cognitive dysfunction rating scale (CCDR): a data-driven and ecologically relevant assessment tool. Vet J. 2011;188:331\u20136.","journal-title":"Vet J"},{"key":"5027_CR2","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.applanim.2015.08.034","volume":"171","author":"FJ Madari","year":"2015","unstructured":"Madari FJ, Katina AS, Smolek T, Novak P, Weissova T, Novak M, et al. Assessment of severity and progression of canine cognitive dysfunction syndrome using the canine dementia scale (CADES). Appl Anim Behav Sci. 2015;171:138\u201345.","journal-title":"Appl Anim Behav Sci"},{"key":"5027_CR3","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1002\/cne.23877","volume":"524","author":"T Smolek","year":"2016","unstructured":"Smolek T, Madari A, Farbakova J, Kandrac O, Jadhav S, Cente M, et al. Tau hyperphosphorylation in synaptosomes and neuroinflammation are associated with canine cognitive impairment. J Comp Neurol. 2016;524:874\u201395.","journal-title":"J Comp Neurol"},{"key":"5027_CR4","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1097\/NEN.0000000000000230","volume":"74","author":"F Schmidt","year":"2015","unstructured":"Schmidt F, Boltze J, Jager C, Hofmann S, Willems N, Seeger J, Hartig W, Stolzing A. Detection and quantification of beta-Amyloid, Pyroglutamyl abeta, and Tau in aged canines. J Neuropathol Exp Neurol. 2015;74:912\u201323.","journal-title":"J Neuropathol Exp Neurol"},{"key":"5027_CR5","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1111\/jvim.13633","volume":"29","author":"T Schutt","year":"2015","unstructured":"Schutt T, Toft N, Berendt M, Function C. Progression of age-related behavioral changes, biomarkers, and survival in dogs more than 8 years old. J Vet Intern Med. 2015;29:1569\u201377.","journal-title":"J Vet Intern Med"},{"key":"5027_CR6","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.2460\/javma.2001.218.1787","volume":"218","author":"JC Neilson","year":"2001","unstructured":"Neilson JC, Hart BL, Cliff KD, Ruehl WW. Prevalence of behavioral changes associated with age-related cognitive impairment in dogs. J Am Vet Med Assoc. 2001;218:1787\u201391.","journal-title":"J Am Vet Med Assoc"},{"key":"5027_CR7","doi-asserted-by":"publisher","first-page":"1128521","DOI":"10.3389\/fnagi.2023.1128521","volume":"15","author":"AD Hines","year":"2023","unstructured":"Hines AD, McGrath S, Latham AS, Kusick B, Mulligan L, Richards ML, et al. Activated gliosis, accumulation of amyloid beta, and hyperphosphorylation of tau in aging canines with and without cognitive decline. Front Aging Neurosci. 2023;15:1128521.","journal-title":"Front Aging Neurosci"},{"key":"5027_CR8","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1292\/jvms.15-0624","volume":"78","author":"M Ozawa","year":"2016","unstructured":"Ozawa M, Chambers JK, Uchida K, Nakayama H. The relation between canine cognitive dysfunction and age-related brain lesions. J Vet Med Sci. 2016;78:997\u20131006.","journal-title":"J Vet Med Sci"},{"key":"5027_CR9","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.pnpbp.2005.01.017","volume":"29","author":"M Pugliese","year":"2005","unstructured":"Pugliese M, Carrasco JL, Andrade C, Mas E, Mascort J, Mahy N. Severe cognitive impairment correlates with higher cerebrospinal fluid levels of lactate and pyruvate in a canine model of senile dementia. Prog Neuropsychopharmacol Biol Psychiatry. 2005;29:603\u201310.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"5027_CR10","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40575-020-00086-8","volume":"7","author":"SR Urfer","year":"2020","unstructured":"Urfer SR, Kaeberlein M, Promislow DEL, Creevy KE. Lifespan of companion dogs seen in three independent primary care veterinary clinics in the united States. Canine Med Genet. 2020;7:7.","journal-title":"Canine Med Genet"},{"key":"5027_CR11","doi-asserted-by":"publisher","first-page":"637","DOI":"10.3233\/JAD-2010-1397","volume":"20","author":"E Head","year":"2010","unstructured":"Head E, Pop V, Sarsoza F, Kayed R, Beckett TL, Studzinski CM, et al. Amyloid-beta peptide and oligomers in the brain and cerebrospinal fluid of aged canines. J Alzheimers Dis. 2010;20:637\u201346.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"5027_CR12","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1111\/bpa.12893","volume":"31","author":"A Abey","year":"2021","unstructured":"Abey A, Davies D, Goldsbury C, Buckland M, Valenzuela M, Duncan T. Distribution of tau hyperphosphorylation in canine dementia resembles early Alzheimer\u2019s disease and other tauopathies. Brain Pathol. 2021;31(1):144\u201362.","journal-title":"Brain Pathol"},{"key":"5027_CR13","doi-asserted-by":"publisher","first-page":"604","DOI":"10.3389\/fnins.2019.00604","volume":"13","author":"SP Mihevc","year":"2019","unstructured":"Mihevc SP, Majdic G. Canine cognitive dysfunction and alzheimer\u2019s disease? - Two facets of the same disease?? Front Neurosci. 2019;13:604.","journal-title":"Front Neurosci"},{"key":"5027_CR14","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1056\/NEJMoa1202753","volume":"367","author":"RJ Bateman","year":"2012","unstructured":"Bateman RJ, Xiong C, Benzinger TL, Fagan AM, Goate A, Fox NC, et al. Dominantly inherited Alzheimer, clinical and biomarker changes in dominantly inherited Alzheimer\u2019s disease. N Engl J Med. 2012;367:795\u2013804.","journal-title":"N Engl J Med"},{"key":"5027_CR15","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1111\/joim.12816","volume":"284","author":"K Blennow","year":"2018","unstructured":"Blennow K, Zetterberg H. Biomarkers for alzheimer\u2019s disease: current status and prospects for the future. J Intern Med. 2018;284:643\u201363.","journal-title":"J Intern Med"},{"key":"5027_CR16","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41591-020-0755-1","volume":"26","author":"S Janelidze","year":"2020","unstructured":"Janelidze S, Mattsson N, Palmqvist S, Smith R, Beach TG, Serrano GE, et al. Plasma P-tau181 in Alzheimer\u2019s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer\u2019s dementia. Nat Med. 2020;26:379\u201386.","journal-title":"Nat Med"},{"key":"5027_CR17","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/s41380-020-00923-z","volume":"26","author":"TK Karikari","year":"2021","unstructured":"Karikari TK, Benedet AL, Ashton NJ, Lantero Rodriguez J, Snellman A, Suarez-Calvet M, et al. Alzheimer\u2019s disease neuroimaging, diagnostic performance and prediction of clinical progression of plasma phospho-tau181 in the Alzheimer\u2019s disease neuroimaging initiative. Mol Psychiatry. 2021;26:429\u201342.","journal-title":"Mol Psychiatry"},{"key":"5027_CR18","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/nature25456","volume":"554","author":"A Nakamura","year":"2018","unstructured":"Nakamura A, Kaneko N, Villemagne VL, Kato T, Doecke J, Dore V, et al. High performance plasma amyloid-beta biomarkers for Alzheimer\u2019s disease. Nature. 2018;554:249\u201354.","journal-title":"Nature"},{"key":"5027_CR19","doi-asserted-by":"publisher","first-page":"2964","DOI":"10.1093\/brain\/awab166","volume":"144","author":"A O\u2019Connor","year":"2021","unstructured":"O\u2019Connor A, Pannee J, Poole T, Arber C, Portelius E, Swift IJ, et al. Plasma amyloid-beta ratios in autosomal dominant Alzheimer\u2019s disease: the influence of genotype. Brain. 2021;144:2964\u201370.","journal-title":"Brain"},{"key":"5027_CR20","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1038\/s41591-023-02476-4","volume":"29","author":"ECB Johnson","year":"2023","unstructured":"Johnson ECB, Bian S, Haque RU, Carter EK, Watson CM, Gordon BA, Ping L, Duong DM, Epstein MP, McDade E, Barthelemy NR, Karch CM, Xiong C, Cruchaga C, Perrin RJ, Wingo AP, Wingo TS, Chhatwal JP, Day GS, Noble JM, Berman SB, Martins R, Graff-Radford NR, Schofield PR, Ikeuchi T, Mori H, Levin J, Farlow M, Lah JJ, Haass C, Jucker M, Morris JC, Benzinger TLS, Roberts BR, Bateman RJ, Fagan AM, Seyfried NT. Levey, and N. Dominantly inherited alzheimer, cerebrospinal fluid proteomics define the natural history of autosomal dominant alzheimer\u2019s disease. Nat Med. 2023;29:1979\u201388.","journal-title":"Nat Med"},{"key":"5027_CR21","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201708763","author":"A Nabers","year":"2018","unstructured":"Nabers A, Perna L, Lange J, Mons U, Schartner J, Guldenhaupt J, et al. Amyloid blood biomarker detects Alzheimer\u2019s disease. EMBO Mol Med. 2018. https:\/\/doi.org\/10.15252\/emmm.201708763.","journal-title":"EMBO Mol Med"},{"key":"5027_CR22","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12014-020-09285-8","volume":"17","author":"M Zhou","year":"2020","unstructured":"Zhou M, Haque RU, Dammer EB, Duong DM, Ping L, Johnson ECB, et al. Targeted mass spectrometry to quantify brain-derived cerebrospinal fluid biomarkers in Alzheimer\u2019s disease. Clin Proteomics. 2020;17:19.","journal-title":"Clin Proteomics"},{"key":"5027_CR23","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1007\/s11357-021-00422-1","volume":"43","author":"SR Urfer","year":"2021","unstructured":"Urfer SR, Darvas M, Czeibert K, Sandor S, Promislow DEL, Creevy KE, et al. Canine cognitive dysfunction (CCD) scores correlate with amyloid beta 42 levels in dog brain tissue. Geroscience. 2021;43:2379\u201386.","journal-title":"Geroscience"},{"key":"5027_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-019-0299-y","volume":"51","author":"JC Lee","year":"2019","unstructured":"Lee JC, Kim SJ, Hong S, Kim Y. Diagnosis of Alzheimer\u2019s disease utilizing amyloid and tau as fluid biomarkers. Exp Mol Med. 2019;51:1\u201310.","journal-title":"Exp Mol Med"},{"key":"5027_CR25","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/S1474-4422(16)00070-3","volume":"15","author":"B Olsson","year":"2016","unstructured":"Olsson B, Lautner R, Andreasson U, Ohrfelt A, Portelius E, Bjerke M, et al. CSF and blood biomarkers for the diagnosis of alzheimer\u2019s disease: a systematic review and meta-analysis. Lancet Neurol. 2016;15:673\u201384.","journal-title":"Lancet Neurol"},{"key":"5027_CR26","doi-asserted-by":"publisher","first-page":"e473","DOI":"10.1212\/WNL.0000000000201479","volume":"100","author":"V Planche","year":"2023","unstructured":"Planche V, Bouteloup V, Pellegrin I, Mangin JF, Dubois B, Ousset PJ, Pasquier F, Blanc F, Paquet C, Hanon O, Bennys K, Ceccaldi M, Annweiler C, Krolak-Salmon P, Godefroy O, Wallon D, Sauvee M, Boutoleau-Bretonniere C, Bourdel-Marchasson I, Jalenques I, Chene G, Dufouil C, Group MS. Validity and performance of blood biomarkers for alzheimer disease to predict dementia risk in a large Clinic-Based cohort. Neurology. 2023;100:e473\u201384.","journal-title":"Neurology"},{"key":"5027_CR27","doi-asserted-by":"crossref","unstructured":"Festa G, Mallamace F, Sancesario GM, Corsaro C, Mallamace D, Fazio E, Arcidiacono L, Garcia Sakai V, Senesi R, Preziosi E, Sancesario G, Andreani C. Aggregation States of Abeta (1\u201340), Abeta(1\u201342) and Abetap(3\u201342) amyloid beta peptides: A SANS study. Int J Mol Sci 2019.","DOI":"10.3390\/ijms20174126"},{"key":"5027_CR28","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s41582-019-0244-7","volume":"15","author":"Y Hou","year":"2019","unstructured":"Hou Y, Dan X, Babbar M, Wei Y, Hasselbalch SG, Croteau DL, et al. Ageing as a risk factor for neurodegenerative disease. Nat Rev Neurol. 2019;15:565\u201381.","journal-title":"Nat Rev Neurol"},{"key":"5027_CR29","doi-asserted-by":"publisher","first-page":"683459","DOI":"10.3389\/fcell.2021.683459","volume":"9","author":"S Azam","year":"2021","unstructured":"Azam S, Haque ME, Balakrishnan R, Kim IS, Choi DK. The ageing brain: molecular and cellular basis of neurodegeneration. Front Cell Dev Biol. 2021;9:683459.","journal-title":"Front Cell Dev Biol"},{"key":"5027_CR30","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1016\/j.bbadis.2013.03.016","volume":"1832","author":"E Head","year":"2013","unstructured":"Head E. A canine model of human aging and Alzheimer\u2019s disease. Biochim Biophys Acta. 2013;1832:1384\u20139.","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"5027_CR31","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.rvsc.2006.06.005","volume":"82","author":"KA Greer","year":"2007","unstructured":"Greer KA, Canterberry SC, Murphy KE. Statistical analysis regarding the effects of height and weight on life span of the domestic dog. Res Vet Sci. 2007;82(2):208\u201314.","journal-title":"Res Vet Sci"},{"key":"5027_CR32","doi-asserted-by":"publisher","first-page":"B171","DOI":"10.1093\/gerona\/52A.3.B171","volume":"52","author":"GJ Patronek","year":"1997","unstructured":"Patronek GJ, Waters DJ, Glickman LT. Comparative longevity of pet dogs and humans: implications for gerontology research. J Gerontol A Biol Sci Med Sci. 1997;52:B171-8.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"5027_CR33","doi-asserted-by":"crossref","unstructured":"C.H. Vite, and E. Head, Aging in the canine and feline brain. Vet Clin North Am Small Anim Pract 44 (2014) 1113-29.","DOI":"10.1016\/j.cvsm.2014.07.008"},{"key":"5027_CR34","doi-asserted-by":"publisher","first-page":"4270","DOI":"10.1007\/s00415-022-11055-5","volume":"269","author":"G Giacomucci","year":"2022","unstructured":"Giacomucci G, Mazzeo S, Bagnoli S, Ingannato A, Leccese D, Berti V, et al. Plasma neurofilament light chain as a biomarker of Alzheimer\u2019s disease in subjective cognitive decline and mild cognitive impairment. J Neurol. 2022;269:4270\u201380.","journal-title":"J Neurol"},{"key":"5027_CR35","doi-asserted-by":"publisher","first-page":"284","DOI":"10.25122\/jml-2022-0251","volume":"16","author":"SS Abed","year":"2023","unstructured":"Abed SS, Hamdan FB, Hussein MM, Al-Mayah QS. Plasma tau and neurofilament light chain as biomarkers of Alzheimer\u2019s disease and their relation to cognitive functions. J Med Life. 2023;16:284\u20139.","journal-title":"J Med Life"},{"key":"5027_CR36","doi-asserted-by":"publisher","first-page":"106267","DOI":"10.1016\/j.nbd.2023.106267","volume":"186","author":"GM Giuffre","year":"2023","unstructured":"Giuffre GM, Quaranta D, Costantini EM, Citro S, Martellacci N, De Ninno G, et al. Cerebrospinal fluid neurofilament light chain and total-tau as biomarkers of neurodegeneration in Alzheimer\u2019s disease and frontotemporal dementia. Neurobiol Dis. 2023;186:106267.","journal-title":"Neurobiol Dis"},{"key":"5027_CR37","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s12877-018-0876-2","volume":"18","author":"N Legdeur","year":"2018","unstructured":"Legdeur N, Heymans MW, Comijs HC, Huisman M, Maier AB, Visser PJ. Age dependency of risk factors for cognitive decline. BMC Geriatr. 2018;18:187.","journal-title":"BMC Geriatr"},{"key":"5027_CR38","doi-asserted-by":"publisher","first-page":"8205","DOI":"10.1523\/JNEUROSCI.1339-04.2004","volume":"24","author":"PD Tapp","year":"2004","unstructured":"Tapp PD, Siwak CT, Gao FQ, Chiou JY, Black SE, Head E, et al. Frontal lobe volume, function, and beta-amyloid pathology in a canine model of aging. J Neurosci. 2004;24:8205\u201313.","journal-title":"J Neurosci"},{"key":"5027_CR39","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1111\/jvim.16184","volume":"35","author":"T Yun","year":"2021","unstructured":"Yun T, Koo Y, Chae Y, Lee D, Kim H, Kim S, et al. Neurofilament light chain as a biomarker of meningoencephalitis of unknown etiology in dogs. J Vet Intern Med. 2021;35:1865\u201372.","journal-title":"J Vet Intern Med"},{"key":"5027_CR40","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1111\/jvim.17033","volume":"38","author":"KM Fowler","year":"2024","unstructured":"Fowler KM, Shinn RL, Rossmeisl JH, Parker RL. Evaluation of neurofilament light chain as a biomarker in dogs with structural and idiopathic epilepsy. J Vet Intern Med. 2024;38:1577\u201382.","journal-title":"J Vet Intern Med"},{"key":"5027_CR41","doi-asserted-by":"publisher","first-page":"1284306","DOI":"10.3389\/fvets.2023.1284306","volume":"10","author":"T Yun","year":"2023","unstructured":"Yun T, Chae Y, Koo Y, Lee D, Kim H, Yang MP, et al. Preliminary study of neurofilament light chain as a biomarker for hypoxia-induced neuronal injury in dogs. Front Vet Sci. 2023;10:1284306.","journal-title":"Front Vet Sci"},{"key":"5027_CR42","doi-asserted-by":"publisher","first-page":"135593","DOI":"10.1016\/j.neulet.2020.135593","volume":"744","author":"J Perino","year":"2021","unstructured":"Perino J, Patterson M, Momen M, Borisova M, Heslegrave A, Zetterberg H, et al. Neurofilament light plasma concentration positively associates with age and negatively associates with weight and height in the dog. Neurosci Lett. 2021;744:135593.","journal-title":"Neurosci Lett"},{"key":"5027_CR43","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1002\/alz.12447","volume":"18","author":"P Chatterjee","year":"2022","unstructured":"Chatterjee P, Pedrini S, Ashton NJ, Tegg M, Goozee K, Singh AK, et al. Diagnostic and prognostic plasma biomarkers for preclinical alzheimer\u2019s disease. Alzheimers Dement. 2022;18:1141\u201354.","journal-title":"Alzheimers Dement"},{"key":"5027_CR44","doi-asserted-by":"publisher","first-page":"e12291","DOI":"10.1002\/dad2.12291","volume":"14","author":"D Shir","year":"2022","unstructured":"Shir D, Graff-Radford J, Hofrenning EI, Lesnick TG, Przybelski SA, Lowe VJ, Knopman DS, Petersen RC, Jack CR Jr., Vemuri P, Algeciras-Schimnich A, Campbell MR, Stricker NH, Mielke MM. Association of plasma glial fibrillary acidic protein (GFAP) with neuroimaging of alzheimer\u2019s disease and vascular pathology. Alzheimers Dement (Amst). 2022;14:e12291.","journal-title":"Alzheimers Dement (Amst)"},{"key":"5027_CR45","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3233\/JAD-151085","volume":"52","author":"T Schutt","year":"2016","unstructured":"Schutt T, Helboe L, Pedersen LO, Waldemar G, Berendt M, Pedersen JT. Dogs with cognitive dysfunction as a spontaneous model for early Alzheimer\u2019s disease: a translational study of neuropathological and inflammatory markers. J Alzheimers Dis. 2016;52:433\u201349.","journal-title":"J Alzheimers Dis"},{"key":"5027_CR46","doi-asserted-by":"publisher","first-page":"551895","DOI":"10.3389\/fvets.2020.551895","volume":"7","author":"Z Vikartovska","year":"2020","unstructured":"Vikartovska Z, Farbakova J, Smolek T, Hanes J, Zilka N, Hornakova L, et al. Novel diagnostic tools for identifying cognitive impairment in dogs: behavior, biomarkers, and pathology. Front Vet Sci. 2020;7:551895.","journal-title":"Front Vet Sci"}],"container-title":["BMC Veterinary Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-025-05027-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12917-025-05027-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-025-05027-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T14:03:13Z","timestamp":1760709793000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcvetres.biomedcentral.com\/articles\/10.1186\/s12917-025-05027-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,17]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5027"],"URL":"https:\/\/doi.org\/10.1186\/s12917-025-05027-w","relation":{},"ISSN":["1746-6148"],"issn-type":[{"value":"1746-6148","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,17]]},"assertion":[{"value":"25 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Experiments performed were approved by the Institutional Animal Care and Use Committee at Colorado State University (Protocol #: 4106 and 1235). Informed consent was obtained from all owners prior to enrollment into the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"617"}}